We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Donor Kidney Transport System Preserves Organ Function

By HospiMedica International staff writers
Posted on 01 Jul 2019
A novel organ preservation and transport platform combines hypothermia and ultrasound to provide optimal conditions during transfer of a transplanted organ.

The Transplant Biomedicals (Barcelona, Spain) Vivian system is a single-use, disposable organ preservation device for kidney transport that is based on hypothermic ultrasound preservation technology (HUPT), a revolutionary proprietary and patented technology that leads to superior preservation of organs during ex-vivo conditions. More...
HUPT works by activating intrinsic protective mechanisms that aid cell survival and tissue regeneration pathways during injury, as well as inducing preservation energy metabolism and inflammatory response reduction pathways.

In the first-in-man safety and performance study of the system held at Hospital Clinic de Barcelona (HCB; Spain), results pointed to an excellent safety profile, with no events related with the device and no donor organs being discarded. Of the 32 patients enrolled in the prospective, single-arm, multi-center study who received a kidney from either brain death standard and extended criteria donors, Vivian was associated with a low (19%) overall rate of delayed graft function (DGF) at 30-days, with a short duration of DGF and length of hospitalization. No recipient suffered from graft primary non-function (PNF).

“A 19% rate of DGF is a remarkable achievement, in particular if we take into consideration the high proportion of cardiac arrest donors (61%) and the mean age (over 60-years) of the donor/recipient population included in the study,” said senior author Fritz Diekmann, MD, head of HCB renal transplant unit. “These results are very encouraging for patients undergoing kidney transplantation, and surpass our clinical daily experience and those reported in the literature in comparison to static cold storage.”

“We believe that Vivian is a platform with the profile of a true game changer in organ, tissue, and cells preservation market,” said Joan Salgado, PhD, CEO of Transplant Biomedicals. “These interim results in kidney transplantation represent a boost to our mission of improving the outcomes in solid organ transplantation and to continue and accelerate further our development activities in cell and tissue preservation.”

The cornerstone of traditional organ preservation is cold ischemic storage. Although this method is intended to reduce the extent of organ damage during transport, significant deterioration of the donated organ still occurs; the longer the organ is kept on ice, the greater the damage. Moreover, the cold storage technique does not enable any resuscitative assessment while the organ is being transported from donor to recipient.

Related Links:
Transplant Biomedicals
Hospital Clinic de Barcelona


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.